Delivery Order SPE2DB20D2104-SPE2DB24FU77F

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $1,245.81, is for the delivery of 4,564,662,496 units of the pharmaceutical product Clomid 50 mg tablets. This is a firm fixed-price delivery order contract with a period of performance through May 21, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clomid 50 mg tablets. The $1,126.32 Firm Fixed Price Delivery Order has a completion date of May 7, 2024 and was awarded on May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,892.71, is a delivery order for Clomid 50 mg tablets with an ultimate completion date of December 3, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,565,534,740 units of Clomid 50mg tablets. The fixed-price delivery order, valued at $1,244.62, has an ultimate completion date of August 22, 2024. The contract has no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award is for the delivery of Clomid 50 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical program. The $1,899.96 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This delivery order is part of a larger indefinite...
The federal contract award with ID SPE2DB20D2104|SPE2DB25FMMUW was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,732.40 firm fixed-price delivery order is for the supply of 30-count tablets of the drug Clomid 50 mg. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,116.48 firm fixed-price delivery order is for the supply of 4,562,925,613 units of the prescription drug Clomid (clomiphene citrate 50 mg tablets) with a period of performance through November 29, 2023. This contract award is a delivery order against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp for the delivery of Clomid (clomiphene citrate) 50 mg tablets in 30-count units. The $10,907.49 contract was awarded on July 29, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 30, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a variety...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,336.72 and is for the delivery of Clomid 50 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,913.48 firm fixed-price delivery order is for the supply of 30-count tablets of the medication Clomid 50 mg. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU77F
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,800.43 Firm Fixed Price Delivery Order provides for the supply of Clomid 50 mg tablets to the government, with a completion date of June 21, 2024.

Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 9/19/24, 9:35 AM